Skip to main content

Table 1 Demographic, clinical, and laboratory characteristics of patients at baseline

From: A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali

Characteristics AL
(n = 155)
DHA–PQ
(n = 155)
p values
Age group, years
 % < 5 years of age 21 23 0.6
 % 5–53 years of age 79 77
Gender categories
 % of female 47 46 0.6
 % of male 53 54
 % of fever 67 69 0.7
 % of anemia 42.7 41.1 0.7
 Median of parasitemia (IQR 25th and 75th percentiles)
Number of trophozoite/μl of blood
24,325 (9450–45,775) 21,200 (9280–38,875) 0.2